Editing MGRS (MGRS)

{{tp|p=38229028|t=2024. Systematic review and meta-analysis of the clinical features of MGRS.|pdf=|usr=}}{{38229028}}
{{tp|p=30510265|t=2019. The evaluation of monoclonal gammopathy of renal significance: a consensus report  of the International Kidney and Monoclonal Gammopathy Research Group |pdf=|usr=}}{{30510265}}
{{tp|p=21700823|t=2011. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits:  correlation with IgG subclass and response to rituximab |pdf=|usr=}}{{21700823}}
{{tp|p=35389534|t=2022. Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.|pdf=|usr=}}{{35389534}}
{{tp|p=34386655|t=2021. A Fresh Perspective on Monoclonal Gammopathies of Renal Significance.|pdf=|usr=}}{{34386655}}
{{tp|p=34175375|t=2022. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.|pdf=|usr=}}{{34175375}}
{{tp|p=33709474|t=2021. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.|pdf=|usr=}}{{33709474}}
{{tp|p=32629844|t=2020. Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond.|pdf=|usr=}}{{32629844}}
{{tp|p=31409583|t=2019. Pathophysiology and management of monoclonal gammopathy of renal significance.|pdf=|usr=}}{{31409583}}
{{tp|p=27526706|t=2016. Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.|pdf=|usr=}}{{27526706}}
{{tp|p=25607108|t=2015. Diagnosis of monoclonal gammopathy of renal significance.|pdf=|usr=}}{{25607108}}
{{tp|p=3079957|t=1986. Renal and systemic kappa light chain deposits and their plasma cell origin identified by immunoelectron microscopy.|pdf=|usr=}}{{3079957}}
{{tp|p=35817530|t=2022. Monoclonal Gammopathy-Related Kidney Diseases.|pdf=|usr=}}{{35817530}}
{{tp|p=35017322|t=2021. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.|pdf=|usr=}}{{35017322}}
{{tp|p=33774084|t=2021. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.|pdf=|usr=}}{{33774084}}
{{tp|p=32199132|t=2020. An update to the pathogenesis for monoclonal gammopathy of renal significance.|pdf=|usr=}}{{32199132}}
{{tp|p=31634325|t=2020. Clinicopathologic Assessment of Monoclonal Immunoglobulin-associated Renal Disease in the Kidney Allograft: A Retrospective Study and Review of the Literature.|pdf=|usr=}}{{31634325}}
{{tp|p=31471332|t=2019. Monoclonal Gammopathy of Renal Significance and its Associated Experimental Models.|pdf=|usr=}}{{31471332}}
{{tp|p=31331759|t=2019. Dysproteinemia and the Kidney: Core Curriculum 2019.|pdf=|usr=}}{{31331759}}
{{tp|p=31301197|t=2020. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.|pdf=|usr=}}{{31301197}}
{{tp|p=26735145|t=2016. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.|pdf=|usr=}}{{26735145}}
{{tp|p=17900464|t=2007. Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases.|pdf=|usr=}}{{17900464}}
{{tp|p=16358223|t=2005. The ultrastructural basis of renal pathology in monoclonal gammopathies.|pdf=|usr=}}{{16358223}}
{{tp|p=3142260|t=1988. Morphologic variants of light-chain deposition disease in the kidney.|pdf=|usr=}}{{3142260}}
{{tp|p=3917604|t=1985. Rapidly progressive glomerulonephritis and monoclonal gammopathy.|pdf=|usr=}}{{3917604}}
{{tp|p=842551|t=1977. Benign monoclonal gammaglobulinemia and glomerulonephritis.|pdf=|usr=}}{{842551}}
{{tp|p=22904123|t=2012. Onco-nephrology: glomerular diseases with cancer.|pdf=|usr=}}{{22904123}}
{{tp|p=26848798|t=2016. IgG Subclass Staining in Routine Renal Biopsy Material.|pdf=|usr=}}{{26848798}}
{{tp|p=30124958|t=2019. Standardized classification and reporting of glomerulonephritis.|pdf=|usr=}}{{30124958}}
{{tp|p=36817291|t=2022. Monoclonal Gammopathy of Renal Significance: Histomorphological Spectrum at a Tertiary Care Center.|pdf=|usr=}}{{36817291}}
{{tp|p=36699747|t=2022. Clinicopathological Profile of Paraprotein-Associated Kidney Disease in Monoclonal Gammopathies: An Observational Study.|pdf=|usr=}}{{36699747}}
{{tp|p=35257069|t=2022. A Diverse Spectrum of Immune Complex- and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma.|pdf=|usr=}}{{35257069}}
{{tp|p=34643486|t=2021. Complement activation and cryoglobulinemia are common in monoclonal gammopathy of renal significance: Data from a case series.|pdf=|usr=}}{{34643486}}
{{tp|p=34501317|t=2021. Acute Kidney Injury in Monoclonal Gammopathies.|pdf=|usr=}}{{34501317}}
{{tp|p=32167383|t=2020. An Unusual Case of Acquired Angioedema and Monoclonal Gammopathy of Renal Significance in a Middle-Aged Caucasian Female.|pdf=|usr=}}{{32167383}}
{{tp|p=30671213|t=2019. Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.|pdf=|usr=}}{{30671213}}
{{tp|p=27526707|t=2016. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?|pdf=|usr=}}{{27526707}}
{{tp|p=9058099|t=1997. Rapidly progressive renal failure occurring in the course of pyoderma gangrenosum and IgA (lambda) monoclonal gammopathy.|pdf=|usr=}}{{9058099}}
{{tp|p=35471002|t=2022. [Monoclonal gammopathies and kidney: a diagnostic challenge without any clues].|pdf=|usr=}}{{35471002}}
{{tp|p=10585324|t=1999. Acute renal failure in a neonate caused by the transplacental transfer of a nephrotoxic paraprotein: successful resolution by exchange transfusion.|pdf=|usr=}}{{10585324}}
{{tp|p=21839367|t=2011. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.|pdf=|usr=}}{{21839367}}
{{tp|p=38250251|t=2024. The spectrum of thrombotic microangiopathy related to monoclonal gammopathy.|pdf=|usr=}}{{38250251}}
{{tp|p=37206284|t=2023. Assessment of current clinical practice throughout the UK for the diagnosis and management of monoclonal gammopathy of renal significance.|pdf=|usr=}}{{37206284}}
{{tp|p=36686103|t=2022. Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report.|pdf=|usr=}}{{36686103}}
{{tp|p=36505449|t=2022. Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment.|pdf=|usr=}}{{36505449}}
{{tp|p=36172352|t=2022. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder.|pdf=|usr=}}{{36172352}}
{{tp|p=35756635|t=2022. Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.|pdf=|usr=}}{{35756635}}
{{tp|p=35483921|t=2022. Diagnosis and management of monoclonal gammopathy of clinical significance.|pdf=|usr=}}{{35483921}}
{{tp|p=35210280|t=2022. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.|pdf=|usr=}}{{35210280}}
{{tp|p=34692719|t=2021. Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review.|pdf=|usr=}}{{34692719}}
{{tp|p=34217367|t=2021. Clinicopathological characteristics of patients with paraproteinemia and renal damage.|pdf=|usr=}}{{34217367}}
{{tp|p=34109201|t=2021. Kidney Biopsy in Patients With Monoclonal Gammopathy: A Multicenter Retrospective Cohort Study.|pdf=|usr=}}{{34109201}}
{{tp|p=32637279|t=2020. Uncommon Presentations of Multiple Myeloma.|pdf=|usr=}}{{32637279}}
{{tp|p=30288263|t=2018. Renal involvement in chronic lymphocytic leukemia.|pdf=|usr=}}{{30288263}}
{{tp|p=29848505|t=2018. Kidney Involvement of Patients with Waldenstrom Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.|pdf=|usr=}}{{29848505}}
{{tp|p=29777014|t=2018. A Case of Monoclonal Gammopathy of Renal Significance.|pdf=|usr=}}{{29777014}}
{{tp|p=29183887|t=2018. How I manage monoclonal gammopathy of undetermined significance.|pdf=|usr=}}{{29183887}}
{{tp|p=29114004|t=2018. Dysproteinemias and Glomerular Disease.|pdf=|usr=}}{{29114004}}
{{tp|p=29043147|t=2017. A case report of paraproteinemia-associated pauci-immune glomerulonephritis - a new form of monoclonal gammopathy of renal significance?|pdf=|usr=}}{{29043147}}
{{tp|p=28716013|t=2017. Long-term renal survival of gamma3-heavy chain deposition disease: a case report.|pdf=|usr=}}{{28716013}}
{{tp|p=27526705|t=2016. Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.|pdf=|usr=}}{{27526705}}
{{tp|p=27416775|t=2016. Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.|pdf=|usr=}}{{27416775}}
{{tp|p=26120578|t=2015. Antineutrophil Cytoplasmic Antibodies-Negative Pauci-Immune Crescentic Glomerulonephritis Associated with Multiple Myeloma.|pdf=|usr=}}{{26120578}}
{{tp|p=25852893|t=2014. Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS).|pdf=|usr=}}{{25852893}}
{{tp|p=24282629|t=2013. Monoclonal gammopathy-associated pauci-immune extracapillary-proliferative glomerulonephritis successfully treated with bortezomib.|pdf=|usr=}}{{24282629}}
{{tp|p=23868898|t=2013. Kidney disease and multiple myeloma.|pdf=|usr=}}{{23868898}}
{{tp|p=23024162|t=2012. Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.|pdf=|usr=}}{{23024162}}
{{tp|p=26019812|t=2012. Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment.|pdf=|usr=}}{{26019812}}
{{tp|p=20462963|t=2010. Kidney disease associated with plasma cell dyscrasias.|pdf=|usr=}}{{20462963}}
{{tp|p=1693473|t=1990. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.|pdf=|usr=}}{{1693473}}
{{tp|p=3918454|t=1985. Glomerular capillary aneurysms in light-chain nephropathy. An ultrastructural proposal of pathogenesis.|pdf=|usr=}}{{3918454}}
{{tp|p=6778218|t=1980. Kappa light chain glomerulosclerosis in multiple myeloma.|pdf=|usr=}}{{6778218}}
{{tp|p=6770693|t=1980. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.|pdf=|usr=}}{{6770693}}
{{tp|p=38106591|t=2023. The Uncertainty Puzzle of Monoclonal Gammopathy of Renal Significance Without Detectable Clones.|pdf=|usr=}}{{38106591}}
{{tp|p=38106576|t=2023. Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones.|pdf=|usr=}}{{38106576}}
{{tp|p=37120733|t=2023. Non-crystalline light chain proximal tubulopathy, a morphologically protean entity.|pdf=|usr=}}{{37120733}}
{{tp|p=36942309|t=2023. Histiocytic Glomerulopathy With Noncrystalline Inclusion Associated With IgG-Kappa Plasma Cell Dyscrasia.|pdf=|usr=}}{{36942309}}
{{tp|p=36856974|t=2023. Lessons for the clinical nephrologist: a rare case with MGRS characterized by combined crystalline light chain proximal tubulopathy and crystal-storing histiocytosis responding to daratumumab.|pdf=|usr=}}{{36856974}}
{{tp|p=36590677|t=2022. Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology.|pdf=|usr=}}{{36590677}}
{{tp|p=35879978|t=2022. Heavy Chain/Light Chain Antibody Immunofluorescence to Identify Monoclonal Plasma Cells in a Case of Plasma Cell-Rich Acute Interstitial Nephritis.|pdf=|usr=}}{{35879978}}
{{tp|p=35570997|t=2022. Validation Study on the Utility of Immunoglobulin Heavy/Light Chain Immunofluorescence in Kidney Biopsies With Potential Monoclonal Gammopathy of Renal Significance Lesions.|pdf=|usr=}}{{35570997}}
{{tp|p=35070693|t=2021. Role of Direct Immunofluorescence Microscopy in Spectrum of Diffuse Proliferative Glomerulonephritis: A Single-Center Study.|pdf=|usr=}}{{35070693}}
{{tp|p=34386655|t=2021. A Fresh Perspective on Monoclonal Gammopathies of Renal Significance.|pdf=|usr=}}{{34386655}}
{{tp|p=34094600|t=2021. Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease.|pdf=|usr=}}{{34094600}}
{{tp|p=34013123|t=2021. A Case of Glomerulopathy Associated With Monoclonal Glomerular Basement Membrane Antibody.|pdf=|usr=}}{{34013123}}
{{tp|p=33921394|t=2021. The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era.|pdf=|usr=}}{{33921394}}
{{tp|p=33912743|t=2021. Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction.|pdf=|usr=}}{{33912743}}
{{tp|p=33275738|t=2020. Monoclonal gammopathies of clinical significance.|pdf=|usr=}}{{33275738}}
{{tp|p=33026700|t=2020. EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma.|pdf=|usr=}}{{33026700}}
{{tp|p=32747354|t=2020. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.|pdf=|usr=}}{{32747354}}
{{tp|p=32643956|t=2020. Monoclonal Gammopathy of Renal Significance-A Rare Renal Presentation: A Review of Cases Reported.|pdf=|usr=}}{{32643956}}
{{tp|p=32531894|t=2020. CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond.|pdf=|usr=}}{{32531894}}
{{tp|p=31701064|t=2019. Pauci-immune Crescentic Glomerulonephritis Due to MGRS Crystalline Nephropathy.|pdf=|usr=}}{{31701064}}
{{tp|p=31592189|t=2019. Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders.|pdf=|usr=}}{{31592189}}
{{tp|p=30762802|t=2019. Dual anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody-positive crescent glomerulonephritis in a patient with monoclonal gammopathy of undetermined significance: A case report.|pdf=|usr=}}{{30762802}}
{{tp|p=30510265|t=2019. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.|pdf=|usr=}}{{30510265}}
{{tp|p=29703839|t=2018. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.|pdf=|usr=}}{{29703839}}
{{tp|p=29416776|t=2018. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.|pdf=|usr=}}{{29416776}}
{{tp|p=25811382|t=2015. The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.|pdf=|usr=}}{{25811382}}
{{tp|p=25194005|t=2015. IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry.|pdf=|usr=}}{{25194005}}
{{tp|p=24772399|t=2014. Hypertension, renal failure, and edema in a 38-year-old man: light chain deposition disease; a case report and review of the literature.|pdf=|usr=}}{{24772399}}
{{tp|p=24733356|t=2014. Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy.|pdf=|usr=}}{{24733356}}
{{tp|p=23087561|t=2012. Light chain deposition disease in a postrenal transplant patient.|pdf=|usr=}}{{23087561}}
{{tp|p=22470380|t=2011. Crescentic glomerulonephritis in IgA multiple myeloma: a case report.|pdf=|usr=}}{{22470380}}
{{tp|p=3102562|t=1987. Light chains and the kidney.|pdf=|usr=}}{{3102562}}
{{tp|p=C10171483|t=2023. MGRS: DIAGNOSIS AND TREATMENT.|pdf=|usr=}}{{C10171483}}
{{tp|p=38200026|t=2024. Development and validation of a diagnostic nomogram model for predicting monoclonal gammopathy of renal significance.|pdf=|usr=}}{{38200026}}
{{tp|p=36216844|t=2022. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.|pdf=|usr=}}{{36216844}}
{{tp|p=34704888|t=2021. A rare case of crescentic glomerulonephritis with monoclonal IgG deposits.|pdf=|usr=}}{{34704888}}
{{tp|p=33796233|t=2021. Clinicopathological characteristics and long-term prognosis of monoclonal immunoglobulin light chain associated Fanconi syndrome.|pdf=|usr=}}{{33796233}}
{{tp|p=31723584|t=2019. The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.|pdf=|usr=}}{{31723584}}
{{tp|p=28316940|t=2017. Monoclonal gammopathy of renal significance: Diagnostic workup.|pdf=|usr=}}{{28316940}}
{{tp|p=35371791|t=2022. Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management.|pdf=|usr=}}{{35371791}}
{{tp|p=35211301|t=2022. Podocytopathy in patients with monoclonal gammopathy: three patients and literature review.|pdf=|usr=}}{{35211301}}
{{tp|p=34858436|t=2021. Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review.|pdf=|usr=}}{{34858436}}
{{tp|p=30419839|t=2018. Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.|pdf=|usr=}}{{30419839}}
{{ttp|p=18817550|t=2008. Ultrastructural pathology of nephropathies with organized deposits: a case series.|pdf=|usr=}}{{18817550}}
{{ttp|p=33163710|t=2020. Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease.|pdf=|usr=}}{{33163710}}
{{tp|p=20455664|t=Ultrastructural immunolabeling in the diagnosis of monoclonal light-and  heavy-chain-related renal diseases.|c=}} {{20455664}}
{{tp|p=25268200|t=Proximal tubulopathies associated with monoclonal light chains: the spectrum of  clinicopathologic manifestations and molecular pathogenesis.|c=}} {{25268200}}
{{tp|p=34010532|t=2021. Monoclonal Gammopathy of Renal Significance |pdf=|usr=}} {{34010532}}
{{tp|p=23533417|t=Aggregates, crystals, gels, and amyloids: intracellular and extracellular  phenotypes at the crossroads of immunoglobulin physicochemical property and cell  physiology.|c=}} {{23533417}}
{{tp|p=22417785|t=Clinicopathologic correlations in multiple myeloma: a case series of 190 patients  with kidney biopsies.|c=}} {{22417785}}
{{tp|p=9759684|t=Renal failure in multiple myeloma: presenting features and predictors of outcome  in 94 patients from a single institution.|c=}} {{9759684}}
{{tp|p=4142093|t=Etiologic agents of immune-deposit disease.|c=}} {{4142093}}
{{tp|p=29456245|t=2018. Animal models of monoclonal immunoglobulin-related renal diseases |pdf=|usr=}}{{29456245}}
{{tp|p=31471332|t=2019. Monoclonal Gammopathy of Renal Significance and its Associated Experimental  Models |pdf=|usr=}}{{31471332}}